Can Fite Biopharma Ltd ADR (CANF) — Strategic Asset Allocation Index
Can Fite Biopharma Ltd ADR (CANF) has a Strategic Asset Allocation Index of 1.8% as of June 2023. Strategic assets (PP&E of $123.00K plus long-term investments of $-) total $123.00K, measured against net assets of $6.87 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See CANF net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Can Fite Biopharma Ltd ADR Strategic Asset Allocation Index (2011–2022)
This chart shows how Can Fite Biopharma Ltd ADR's Strategic Asset Allocation Index has evolved across 11 annual periods from 2011 to 2022. As of June 2023, the index stands at 1.8%, representing strategic assets of $123.00K against net assets of $6.87 Million USD. For live market cap and overall valuation, see CANF market cap overview.
Annual Strategic Asset Allocation Index for Can Fite Biopharma Ltd ADR (2011–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Can Fite Biopharma Ltd ADR from 2011 to 2022, covering 11 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See CANF net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 2.8% | $126.00K | $126.00K | $- | $4.47 Million | ▲ +1.5 pp |
| 2021 | 1.3% | $185.00K | $185.00K | $- | $14.38 Million | ▼ -0.7 pp |
| 2020 | 2.0% | $123.00K | $123.00K | $- | $6.07 Million | ▼ -2.8 pp |
| 2019 | 4.8% | $118.00K | $118.00K | $- | $2.44 Million | ▲ +3.3 pp |
| 2018 | 1.6% | $47.00K | $47.00K | $0.00 | $3.02 Million | ▼ -29.3 pp |
| 2017 | 30.9% | $942.66K | $28.00K | $914.66K | $3.05 Million | ▲ +29.8 pp |
| 2016 | 1.0% | $40.00K | $40.00K | $- | $3.87 Million | ▲ +0.4 pp |
| 2015 | 0.7% | $67.90K | $67.90K | $- | $10.44 Million | ▲ +0.2 pp |
| 2014 | 0.5% | $34.00K | $34.00K | $- | $6.86 Million | ▼ -0.4 pp |
| 2013 | 0.9% | $40.00K | $40.00K | $- | $4.46 Million | ▼ -1.3 pp |
| 2011 | 2.2% | $73.00K | $73.00K | $- | $3.29 Million | — |